Fangusaro J, Onar-Thomas A, Young Poussaint T, Lensing S, et al. A Phase 2 PBTC Study of Selumetinib for Recurrent/Progressive Pediatric Low-Grade Glioma: Strata 2, 5, and 6 with Long-term Outcomes on Strata 1, 3, and 4. Neuro Oncol 2025 Apr 17:noaf065. doi: 10.1093.
PMID: 40241281